Table 2 Demographics of participants in the Auto-Recruit Outpatient System by ADT usage (≤ 1 year vs. >1 year).

From: Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient system

 

Total

ADT Usage ≤ 1 Year

ADT Usage > 1 Year

P value

N

251

 

138

 

113

  

Age

76.0

(69.0, 83.0)

71.5

(67.0, 79.3)

76.0

(68.0, 81.0)

0.128

Height

163.8

(160.0, 168.0)

165.5

(161.7, 169.4)

163.5

(160.0, 169.1)

0.111

Weight

68.0

(59.5, 75.2)

69.7

(63.0, 76.9)

69.6

(61.2, 75.0)

0.614

BMI

25.1

(22.6, 27.6)

25.4

(23.1, 28.1)

25.6

(23.1, 28.1)

0.913

T-score (minimal)

-1.9

(-2.6, -1.1)

-1.7

(-2.3, -0.9)

-2.1

(-2.8, -1.2)

0.009**

T-score minimal group

      

0.039*

≥-1

61

(24.3%)

41

(29.7%)

20

(17.7%)

 

-1.1~-2.5

119

(47.4%)

65

(47.1%)

54

(47.8%)

 

≤-2.5

71

(28.3%)

32

(23.2%)

39

(34.5%)

 

Incomplete screening

63

(25.1%)

33

(23.9%)

30

(26.5%)

0.632

FRAX (major)

7.2

(4.9, 9.1)

6.7

(4.8, 9.1)

7.7

(5.2, 9.2)

0.193

FRAX (hip)

3.1

(1.5, 5.4)

2.7

(1.3, 5.4)

3.3

(1.8, 5.4)

0.300

Old fracture

29

(14.9%)

15

(13.9%)

14

(16.1%)

0.667

Calcium supplement use

Before screening

41

(16.3%)

20

(14.5%)

21

(18.6%)

0.383

Bone-modifying agent

       

Before screening

18

(7.2%)

2

(1.4%)

16

(14.2%)

< 0.001**

  1. Chi-square test or Mann-Whitney U test. *p < 0.05, **p < 0.01